Cameron R. Nelson
Directeur Financier/CFO chez Mati Therapeutics, Inc.
Profil
Cameron R.
Nelson is currently the Chief Financial Officer at Mati Therapeutics, Inc. Previously, he worked as the Chief Financial Officer & Senior Vice President at QLT, Inc. from 2011 to 2012.
Mr. Nelson holds an MBA from Dartmouth College and an undergraduate degree from the University of British Columbia.
Postes actifs de Cameron R. Nelson
| Sociétés | Poste | Début |
|---|---|---|
Mati Therapeutics, Inc.
 Mati Therapeutics, Inc. BiotechnologyHealth Technology Mati Therapeutics, Inc. operates as biotechnology company. It develops non-invasive sustained drug delivery platform to treat ocular diseases, in particular glaucoma. The company was founded by Robert Lee Butchofsky and Christopher A. Muller and is headquartered in Austin, TX. | Directeur Financier/CFO | - |
Anciens postes connus de Cameron R. Nelson
| Sociétés | Poste | Fin |
|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Directeur Financier/CFO | 09/07/2012 |
Formation de Cameron R. Nelson
| Dartmouth College | Masters Business Admin |
| University of British Columbia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Mati Therapeutics, Inc.
Mati Therapeutics, Inc. BiotechnologyHealth Technology Mati Therapeutics, Inc. operates as biotechnology company. It develops non-invasive sustained drug delivery platform to treat ocular diseases, in particular glaucoma. The company was founded by Robert Lee Butchofsky and Christopher A. Muller and is headquartered in Austin, TX. | Health Technology |
